Merit Medical Systems(MMSI)
$84.34-0.07 (-0.08%)
MMSI
Merit Medical Systems financials statements
$84.34
At close:-0.07 (-0.08%)
Want to see MMSI full AI Analyst Report?
Merit Medical Systems (MMSI) Ratios
351 Followers
Merit Medical Systems Ratios
MMSI's free cash flow for Q3 2026 was $52.25M. For the 2026 fiscal year, MMSI's free cash flow was decreased by $-13.02M and operating cash flow was $65.27M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.34 | 4.27 | 5.45 | 2.40 | 2.04 |
| Quick Ratio | 2.95 | 2.85 | 3.95 | 1.19 | 1.10 |
| Cash Ratio | 1.87 | 1.74 | 2.88 | 0.26 | 0.29 |
| Solvency Ratio | 0.24 | 0.23 | 0.17 | 0.32 | 0.24 |
| Operating Cash Flow Ratio | 1.24 | 1.02 | 0.71 | 0.52 | 0.62 |
| Short-Term Operating Cash Flow Coverage | 27.34 | 0.00 | 0.00 | 5.14 | 7.71 |
| Net Current Asset Value | $ -61.47M | $ -115.47M | $ -14.77M | $ 9.52M | $ -126.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.33 | 0.33 | 0.38 | 0.17 | 0.20 |
| Debt-to-Equity Ratio | 0.57 | 0.58 | 0.74 | 0.24 | 0.31 |
| Debt-to-Capital Ratio | 0.36 | 0.37 | 0.43 | 0.20 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.35 | 0.41 | 0.14 | 0.18 |
| Financial Leverage Ratio | 1.70 | 1.75 | 1.93 | 1.45 | 1.59 |
| Debt Service Coverage Ratio | 7.76 | 7.83 | 13.62 | 6.05 | 6.14 |
| Interest Coverage Ratio | 6.97 | 4.99 | 7.99 | 13.81 | 11.58 |
| Debt to Market Cap | 0.16 | 0.13 | 0.19 | 0.05 | 0.07 |
| Interest Debt Per Share | 15.63 | 14.19 | 15.75 | 5.04 | 5.89 |
| Net Debt to EBITDA | 1.35 | 1.53 | 1.33 | 1.22 | 1.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.65% | 47.43% | 46.44% | 45.10% | 45.16% |
| EBIT Margin | 13.03% | 11.74% | 10.15% | 7.73% | 5.51% |
| EBITDA Margin | 21.92% | 20.20% | 18.20% | 15.74% | 14.42% |
| Operating Profit Margin | 12.17% | 11.48% | 9.86% | 7.61% | 5.67% |
| Pretax Profit Margin | 11.28% | 11.06% | 8.91% | 7.18% | 5.02% |
| Net Profit Margin | 8.48% | 8.87% | 7.51% | 6.47% | 4.51% |
| Continuous Operations Profit Margin | 8.48% | 8.87% | 7.51% | 6.47% | 4.51% |
| Net Income Per EBT | 75.17% | 80.24% | 84.23% | 90.18% | 89.87% |
| EBT Per EBIT | 92.71% | 96.34% | 90.44% | 94.37% | 88.51% |
| Return on Assets (ROA) | 4.78% | 4.98% | 4.06% | 4.48% | 2.94% |
| Return on Equity (ROE) | 8.11% | 8.73% | 7.85% | 6.51% | 4.66% |
| Return on Capital Employed (ROCE) | 7.54% | 7.07% | 5.84% | 6.07% | 4.31% |
| Return on Invested Capital (ROIC) | 5.64% | 5.65% | 4.89% | 5.35% | 3.80% |
| Return on Tangible Assets | 7.83% | 8.26% | 5.84% | 7.25% | 5.01% |
| Earnings Yield | 2.46% | 2.14% | 2.16% | 1.86% | 1.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.77 | 6.49 | 6.64 | 6.45 | 6.22 |
| Payables Turnover | 12.85 | 10.41 | 10.21 | 9.22 | 10.60 |
| Inventory Turnover | 2.33 | 2.33 | 2.22 | 2.38 | 2.66 |
| Fixed Asset Turnover | 2.94 | 3.00 | 2.82 | 2.57 | 2.46 |
| Asset Turnover | 0.56 | 0.56 | 0.54 | 0.69 | 0.65 |
| Working Capital Turnover Ratio | 2.01 | 1.68 | 2.07 | 4.15 | 4.38 |
| Cash Conversion Cycle | 182.07 | 177.86 | 183.88 | 170.67 | 161.68 |
| Days of Sales Outstanding | 53.88 | 56.28 | 54.94 | 56.59 | 58.70 |
| Days of Inventory Outstanding | 156.60 | 156.64 | 164.68 | 153.65 | 137.43 |
| Days of Payables Outstanding | 28.42 | 35.06 | 35.74 | 39.57 | 34.45 |
| Operating Cycle | 210.48 | 212.92 | 219.62 | 210.24 | 196.13 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.03 | 3.79 | 2.52 | 2.01 | 2.62 |
| Free Cash Flow Per Share | 3.59 | 3.14 | 1.88 | 1.22 | 2.12 |
| Dividend Paid and CapEx Coverage Ratio | 3.51 | 5.80 | 3.95 | 2.54 | 5.27 |
| Capital Expenditure Coverage Ratio | 3.51 | 5.80 | 3.95 | 2.54 | 5.27 |
| Operating Cash Flow Coverage Ratio | 0.33 | 0.28 | 0.16 | 0.41 | 0.45 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.16 | 0.12 | 0.10 | 0.14 |
| Free Cash Flow Yield | 4.08% | 3.25% | 2.48% | 1.73% | 3.41% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 40.62 | 46.72 | 46.34 | 53.84 | 72.19 |
| Price-to-Sales (P/S) Ratio | 3.44 | 4.15 | 3.48 | 3.49 | 3.25 |
| Price-to-Book (P/B) Ratio | 3.29 | 4.08 | 3.64 | 3.51 | 3.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.53 | 30.81 | 40.34 | 57.92 | 29.32 |
| Price-to-Operating Cash Flow Ratio | 17.53 | 25.50 | 30.14 | 35.10 | 23.76 |
| Price-to-Earnings Growth (PEG) Ratio | 8.41 | 1.78 | 1.84 | 1.03 | -0.12 |
| Enterprise Value Multiple | 17.06 | 22.08 | 20.44 | 23.37 | 24.24 |
| Enterprise Value | 5.66B | 6.05B | 4.68B | 4.23B | 3.76B |
| EV to EBITDA | 17.06 | 22.08 | 20.44 | 23.37 | 24.24 |
| EV to Sales | 3.74 | 4.46 | 3.72 | 3.68 | 3.49 |
| EV to Free Cash Flow | 26.65 | 33.10 | 43.15 | 61.12 | 31.48 |
| EV to Operating Cash Flow | 19.05 | 27.40 | 32.24 | 37.04 | 25.51 |
| Tangible Book Value Per Share | 9.12 | 7.17 | 8.58 | 8.96 | 6.39 |
| Shareholders’ Equity Per Share | 26.78 | 23.69 | 20.87 | 20.15 | 18.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.20 | 0.16 | 0.10 | 0.10 |
| Revenue Per Share | 25.60 | 23.30 | 21.83 | 20.26 | 19.14 |
| Net Income Per Share | 2.17 | 2.07 | 1.64 | 1.31 | 0.86 |
| Tax Burden | 0.75 | 0.80 | 0.84 | 0.90 | 0.90 |
| Interest Burden | 0.87 | 0.94 | 0.88 | 0.93 | 0.91 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
| SG&A to Revenue | 0.30 | 0.28 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
| Income Quality | 2.31 | 1.83 | 1.54 | 1.53 | 3.04 |
Currency in USD

